Paula Cloghessy's most recent trade in Kailera Therapeutics Inc. was a trade of 60,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kailera Therapeutics Inc | Paula Cloghessy | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Kailera Therapeutics Inc | Paula Cloghessy | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Paula Cloghessy | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 95,000 | 95,000 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | Paula Cloghessy | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 47,500 | 47,500 | - | - | Restricted Stock Units | |
| Seres Therapeutics Inc | Paula Cloghessy | See Remarks | Grant, award, or other acquisition of securities at price $ 3.15 per share. | 05 Jul 2022 | 31,746 | 31,746 (0%) | 0% | 3.2 | 100,000 | COMMON STOCK |
| Seres Therapeutics Inc | Paula Cloghessy | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 190,000 | 190,000 | - | - | Stock Options (right to buy) |